Sponsor or institution
Clinical trials and research at German Cancer Research Center
As of November 12, 2026, Find a Trial lists 8 clinical trials run by German Cancer Research Center that are recruiting, at sites in 3 countries (most in Germany (8), Italy (1), Spain (1)). By phase: Phase 2 (1), Phase 1 (1), Early Phase 1 (1). There are also 1 NIH-funded research project at this institution, with $506,676 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1NIH research projects
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using genome and RNA analysis to guide treatment for advanced rare cancers | — | Augsburg and 15 other locations | Recruiting | Mar 3, 2025 |
| Using AI to diagnose melanoma in young patients | — | Tübingen and 2 other locations | Recruiting | Oct 1, 2024 |
| New bispecific antibody treatment for colorectal cancer | Phase 1 | Tübingen, Baden-Wurttemberg | Recruiting | Aug 21, 2023 |
| Genomics-guided precision oncology for early high-risk breast cancer | — | Augsburg and 11 other locations | Recruiting | Jun 15, 2023 |
| Using molecular profiling to guide treatment for rare cancers | — | Heidelberg | Recruiting | May 10, 2023 |
| Genomics-guided precision medicine for metastatic breast cancer | — | Augsburg and 11 other locations | Recruiting | Dec 15, 2022 |
| Genomics-guided therapy for early breast cancer after initial treatment | Phase 2 | Heidelberg, Baden-Wurttemberg and 8 other locations | Recruiting | Apr 18, 2022 |
| New HPV vaccine tested in healthy volunteers | Early Phase 1 | Heidelberg | Recruiting | Jan 26, 2022 |
All recruiting trials (8)
-
Using genome and RNA analysis to guide treatment for advanced rare cancers
This project will test whether using detailed tumor DNA, RNA and methylation analyses to guide treatment helps adults with advanced rare cancers respond better than standard care.
-
Using AI to diagnose melanoma in young patients
This study is testing if artificial intelligence can help doctors better identify melanoma in children and young adults by looking at skin images.
-
New bispecific antibody treatment for colorectal cancer
This study is testing a new antibody treatment for people with advanced colorectal cancer who haven't had success with other therapies to see if it can help their immune system fight the cancer better.
-
Genomics-guided precision oncology for early high-risk breast cancer
This study is testing if analyzing the genes of early-stage breast cancer tumors can help find better treatment options for patients who don't respond well to standard chemotherapy.
-
Using molecular profiling to guide treatment for rare cancers
This study is trying to see if using detailed genetic information can help doctors choose better treatments for adults with rare cancers that don’t have standard options.
-
Genomics-guided precision medicine for metastatic breast cancer
This study is testing whether using genetic information from tumors and blood samples can help doctors create personalized treatment plans for people with metastatic breast cancer.
-
Genomics-guided therapy for early breast cancer after initial treatment
This study is testing if personalized treatment plans based on genetic information can help people with early-stage breast cancer who didn't fully respond to initial therapy avoid relapse.
-
New HPV vaccine tested in healthy volunteers
This study is testing a new HPV vaccine in healthy adults aged 18-45 to see if it can safely boost their immune response against different types of HPV that can cause cancer.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting protein degradation to treat advanced childhood tumors
This study is working on new treatments for kids with solid tumors that haven't responded to regular therapies, using cutting-edge methods to target the specific proteins that fuel these cancers, with the hope of finding better options for young patients.
Quick answers
How many clinical trials run by German Cancer Research Center are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Germany (8 trials), Italy (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.